ArticleFrontiers in neuroscience2022

Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial.

Mehran Rahimlou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.